13F HOLDINGS REPORT
Medicxi Ventures Management (Jersey) Ltd
Quarter ended Q1 2023 · Filed January 31, 2023 · Accession 0000950123-23-000545
Total Value
$238.1M
Positions
6
Other Managers
1
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VAXCYTE INC | PCVX | 1,457,300 | $69.9M | 29.35% |
| 2 | CENTESSA PHARMACEUTICALS PLC | CNTA | 19,963,157 | $61.9M | 25.99% |
| 3 | AURA BIOSCIENCES INC | AURA | 3,039,892 | $31.9M | 13.41% |
| 4 | PHATHOM PHARMACEUTICALS INC | PHAT | 2,484,274 | $27.9M | 11.71% |
| 5 | MERUS N V | N5749R100 | 1,600,000 | $24.8M | 10.40% |
| 6 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 2,000,000 | $21.8M | 9.16% |